Automated immunology testing platform with reagents
Ended Purchase Order Awarded Last action
- Contract number
- W9114F20P0047
- Awardee
-
Bio - Rad Laboratories Gesellschaft MIT Beschraenkter Haftung UEI WRZLAH8SEPG3 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $385,147
Award facts
- Opportunity
-
- Automated Immunology Testing Platform - CPRR Pre-Solicitation · W9114F20Q0051 · Posted Apr 9, 2020
- Automated Immunology Testing Platform - CPRR Award Notice · Posted Oct 20, 2020
- Automated Immunology Testing Platform - CPRR Solicitation · Posted Apr 23, 2020
- Contract value 100% obligated
- $385,146.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$15,937 | |
| Supplemental Agreement for work within scope | $100,070 | |
| Supplemental Agreement for work within scope | -$139,340 | |
| Supplemental Agreement for work within scope | $104,466 | |
| Exercise an Option | $112,605 | |
| Exercise an Option | $109,156 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $114,126 |
About this award
The U.S. Defense Health Agency awarded a $385,146.70 firm-fixed-price purchase order to Bio-Rad Laboratories Gesellschaft mit beschränkter Haftung (Bio-Rad GMBH), a subsidiary of the global life sciences company Bio-Rad Laboratories, Inc. The contract is for an automated immunology testing platform with reagents to support the Department of Pathology and Area Laboratory Services at Landstuhl Regional Medical Center in Germany. The system must be capable of continuously operating and performing a minimum of 100 tests per hour using FDA-approved chemiluminescence or fluorescence-based assays for specific analytes. This contract does not involve any set-aside provisions. Bio-Rad GMBH has a history of providing laboratory equipment, reagents, and services to U.S. federal agencies, including the Army Medical Command, through both prime contracts and subcontracts.
Quick answers
Who was awarded contract W9114F20P0047?
W9114F20P0047 was awarded to Bio - Rad Laboratories Gesellschaft MIT Beschraenkter Haftung by Medical Command (Department of the Army) on July 24, 2020.
How much is contract W9114F20P0047 worth?
The government has obligated $385,147 on W9114F20P0047.
Which agency awarded contract W9114F20P0047?
Medical Command (Department of the Army) awarded W9114F20P0047, with funding from Defense Health Agency (Department of Defense).
Was contract W9114F20P0047 competed?
The extent of competition for W9114F20P0047 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award